Which ILAR categories of juvenile idiopathic arthritis (JIA) fall into the ACR treatment group with active disease in only 4 or fewer joints?

Updated: Jul 25, 2019
  • Author: David D Sherry, MD; Chief Editor: Lawrence K Jung, MD  more...
  • Print

According to ACR guidelines, the treatment group that comprises patients who have developed active arthritis in only 4 or fewer joints total throughout their disease course includes patients in the International League of Associations for Rheumatology (ILAR) categories of persistent oligoarthritis, as well as patients with psoriatic arthritis, enthesitis-related arthritis, and undifferentiated arthritis. [2]

In this treatment group, escalation of therapy typically proceeds from NSAIDs to intra-articular glucocorticoid injections to methotrexate to TNF-α inhibitors.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!